Literature DB >> 21039341

Novel Nox homologues in the vasculature: focusing on Nox4 and Nox5.

Augusto C Montezano1, Dylan Burger, Graziela S Ceravolo, Hiba Yusuf, Maria Montero, Rhian M Touyz.   

Abstract

The Noxes (NADPH oxidases) are a family of ROS (reactive oxygen species)-generating enzymes. Of the seven family members, four have been identified as important sources of ROS in the vasculature: Nox1, Nox2, Nox4 and Nox5. Although Nox isoforms can be influenced by the same stimulus and co-localize in cellular compartments, their tissue distribution, subcellular regulation, requirement for cofactors and NADPH oxidase subunits and ability to generate specific ROS differ, which may help to understand the multiplicity of biological functions of these oxidases. Nox4 and Nox5 are the newest isoforms identified in the vasculature. Nox4 is the major isoform expressed in renal cells and appear to produce primarily H2O2. The Nox5 isoform produces ROS in response to increased levels of intracellular Ca2+ and does not require the other NADPH oxidase subunits for its activation. The present review focuses on these unique Noxes, Nox4 and Nox5, and provides novel concepts related to the regulation and interaction in the vasculature, and discusses new potential roles for these isoforms in vascular biology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21039341     DOI: 10.1042/CS20100384

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  42 in total

Review 1.  Cell signaling of angiotensin II on vascular tone: novel mechanisms.

Authors:  Aurelie Nguyen Dinh Cat; Rhian M Touyz
Journal:  Curr Hypertens Rep       Date:  2011-04       Impact factor: 5.369

Review 2.  The role of oxysterols in vascular ageing.

Authors:  Simona Gargiulo; Paola Gamba; Gabriella Testa; Gabriella Leonarduzzi; Giuseppe Poli
Journal:  J Physiol       Date:  2016-01-19       Impact factor: 5.182

3.  Hsp70 regulation on Nox4/p22phox and cytoskeletal integrity as an effect of losartan in vascular smooth muscle cells.

Authors:  Andrea Fernanda Gil Lorenzo; Victoria Bocanegra; María Eugenia Benardon; Valeria Cacciamani; Patricia G Vallés
Journal:  Cell Stress Chaperones       Date:  2013-06-13       Impact factor: 3.667

Review 4.  Protecting against vascular disease in brain.

Authors:  Frank M Faraci
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-18       Impact factor: 4.733

5.  NOX5 as a therapeutic target in cerebral ischemic injury.

Authors:  Luciana Simão do Carmo; Bradford C Berk; David G Harrison
Journal:  J Clin Invest       Date:  2019-03-18       Impact factor: 14.808

6.  Targeting NADPH oxidase decreases oxidative stress in the transgenic sickle cell mouse penis.

Authors:  Biljana Musicki; Tongyun Liu; Sena F Sezen; Arthur L Burnett
Journal:  J Sex Med       Date:  2012-05-23       Impact factor: 3.802

Review 7.  Regulation of cellular communication by signaling microdomains in the blood vessel wall.

Authors:  Marie Billaud; Alexander W Lohman; Scott R Johnstone; Lauren A Biwer; Stephanie Mutchler; Brant E Isakson
Journal:  Pharmacol Rev       Date:  2014-03-26       Impact factor: 25.468

Review 8.  Drug Treatment of Hypertension: Focus on Vascular Health.

Authors:  Alan C Cameron; Ninian N Lang; Rhian M Touyz
Journal:  Drugs       Date:  2016-10       Impact factor: 9.546

9.  (Pro)renin receptor decoy peptide PRO20 protects against adriamycin-induced nephropathy by targeting the intrarenal renin-angiotensin system.

Authors:  Renfei Luo; Kevin Yang; Fei Wang; Chuanming Xu; Tianxin Yang
Journal:  Am J Physiol Renal Physiol       Date:  2020-08-31

Review 10.  Which NADPH oxidase isoform is relevant for ischemic stroke? The case for nox 2.

Authors:  Timo Kahles; Ralf P Brandes
Journal:  Antioxid Redox Signal       Date:  2012-08-20       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.